189 related articles for article (PubMed ID: 19372181)
1. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Mucositis: from febrile neutropenia to febrile mucositis.
Blijlevens NM; Logan RM; Netea MG
J Antimicrob Chemother; 2009 May; 63 Suppl 1():i36-40. PubMed ID: 19372181
[TBL] [Abstract][Full Text] [Related]
2. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Summary and comments.
Sinkó J; Kullberg BJ; Edwards JE; Anaissie E
J Antimicrob Chemother; 2009 May; 63 Suppl 1():i41-3. PubMed ID: 19372182
[No Abstract] [Full Text] [Related]
3. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
Klastersky J
J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
[TBL] [Abstract][Full Text] [Related]
4. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Where do we go from here?
Pizzo PA
J Antimicrob Chemother; 2009 May; 63 Suppl 1():i16-7. PubMed ID: 19372174
[TBL] [Abstract][Full Text] [Related]
5. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Fever and neutropenia: the early years.
Bodey GP
J Antimicrob Chemother; 2009 May; 63 Suppl 1():i3-13. PubMed ID: 19372179
[TBL] [Abstract][Full Text] [Related]
6. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why monotherapy?
Williams KJ
J Antimicrob Chemother; 2009 May; 63 Suppl 1():i18-20. PubMed ID: 19372175
[TBL] [Abstract][Full Text] [Related]
7. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Moulds: diagnosis and treatment.
Verweij PE; Maertens J
J Antimicrob Chemother; 2009 May; 63 Suppl 1():i31-5. PubMed ID: 19372180
[TBL] [Abstract][Full Text] [Related]
8. Empiric versus preemptive therapy in the management of febrile neutropenia in the patient being treated for hematologic malignancy.
de Pauw BE; Rubin RH
Transpl Infect Dis; 2006 Mar; 8(1):1-2. PubMed ID: 16623814
[No Abstract] [Full Text] [Related]
9. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Prevention of mould infections.
Maschmeyer G
J Antimicrob Chemother; 2009 May; 63 Suppl 1():i27-30. PubMed ID: 19372178
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex infection as possible etiology for febrile neutropenia and mucositis in patients treated for hematological malignancies.
Kubesová H; Penka M; Král Z; Adam Z; Vásová I; Tomíska M; Vorlícek J
Acta Med Austriaca; 1998; 25(2):57-60. PubMed ID: 9681044
[TBL] [Abstract][Full Text] [Related]
11. Febrile mucositis in haematopoietic SCT recipients.
van der Velden WJ; Blijlevens NM; Feuth T; Donnelly JP
Bone Marrow Transplant; 2009 Jan; 43(1):55-60. PubMed ID: 18762766
[TBL] [Abstract][Full Text] [Related]
12. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Management of mycoses in neutropenic patients: a brief history, 1960-2008.
Bennett JE
J Antimicrob Chemother; 2009 May; 63 Suppl 1(Suppl 1):i23-6. PubMed ID: 19372177
[TBL] [Abstract][Full Text] [Related]
13. Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
Pereira CA; Petrilli AS; Carlesse FA; Luisi FA; da Silva KV; de Martino Lee ML
J Microbiol Immunol Infect; 2009 Apr; 42(2):141-7. PubMed ID: 19597646
[TBL] [Abstract][Full Text] [Related]
14. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Moulds and man.
Meis JF
J Antimicrob Chemother; 2009 May; 63 Suppl 1():i21-2. PubMed ID: 19372176
[TBL] [Abstract][Full Text] [Related]
15. Mucositis in malignant hematology.
Niscola P
Expert Rev Hematol; 2010 Feb; 3(1):57-65. PubMed ID: 21082934
[TBL] [Abstract][Full Text] [Related]
16. Implications of treatment-induced mucosal barrier injury.
Blijlevens NM
Curr Opin Oncol; 2005 Nov; 17(6):605-10. PubMed ID: 16224241
[TBL] [Abstract][Full Text] [Related]
17. [Optimal administration of antimicrobial agents for febrile neutropenia in patients with hematological malignancies].
Nomura K; Ishida Y
Nihon Rinsho; 2010 Jul; 68(7):1403-11. PubMed ID: 20662227
[TBL] [Abstract][Full Text] [Related]
18. Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis.
van der Velden WJ; Herbers AH; Netea MG; Blijlevens NM
Br J Haematol; 2014 Nov; 167(4):441-52. PubMed ID: 25196917
[TBL] [Abstract][Full Text] [Related]
19. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Proceedings of a symposium to honor the career of Professor Ben E. De Pauw.
J Antimicrob Chemother; 2009 May; 63 Suppl 1():i1-43. PubMed ID: 19514105
[No Abstract] [Full Text] [Related]
20. Malaria parasitemia associated with febrile neutropenia in African patients undergoing chemotherapy for haematological malignancies. A report of three patients.
Rapoport BL; Uys A
Chemotherapy; 2008; 54(2):117-9. PubMed ID: 18303260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
